Combination pharmacotherapy for achievement and maintenance of vascular patency.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 19064809.
- Also identified by DOI 10.1161/STROKEAHA.108.529800.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Acute ischemic stroke results from an abrupt interruption of focal cerebral blood flow. In the majority of cases, this interruption is caused by an acute thromboembolism. Arising from the clinical trials in acute myocardial infarction, combination pharmacotherapy is gaining significant interest as a potential method to improve current thrombolytic treatment in acute ischemic stroke. This article reviews the scientific rationale and available evidence for the potential options to improve current pharmacologic therapy for achieving and maintaining vascular patency in acute ischemic stroke.
Medical subject headings
- Drug Therapy
- Stroke
- Vascular Patency